MEDI holdings
All 40 positions of Harbor Health Care ETF.
Positions
40
Top 10 weight
68.2%
Effective holdings
12.0
1 / sum of squared weights
In stocks
99.5%
In bonds
0.0%
Outside the US
27.3%
Asset mix
Sectors
83% of stocks classifiedCountries
Holdings
| # | Holding | Type | Weight | Value | Shares / par | Country |
|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly & Co. | Equity | 20.10% | $5.5M | 5,929 | US |
| 2 | Ascendis Pharma A/S | Equity | 15.56% | $4.3M | 18,699 | DK |
| 3 | LEGNLegend Biotech Corporation American Depositary Shares | Equity | 5.13% | $1.4M | 60,189 | KY |
| 4 | ABBVABBVIE INC. | Equity | 4.78% | $1.3M | 6,235 | US |
| 5 | PCVXVaxcyte, Inc. Common Stock | Equity | 4.64% | $1.3M | 22,357 | US |
| 6 | ISRGIntuitive Surgical Inc. | Equity | 4.53% | $1.2M | 2,727 | US |
| 7 | RYTMRhythm Pharmaceuticals, Inc. Common Stock | Equity | 3.79% | $1.0M | 12,831 | US |
| 8 | INSMInsmed, Inc. | Equity | 3.71% | $1.0M | 7,509 | US |
| 9 | ABVXAbivax SA American Depositary Shares | Equity | 3.54% | $975K | 8,304 | FR |
| 10 | DHRDanaher Corporation | Equity | 2.43% | $669K | 3,739 | US |
| 11 | RVMDRevolution Medicines, Inc. Common Stock | Equity | 2.38% | $655K | 4,546 | US |
| 12 | NTRANatera, Inc. Common Stock | Equity | 2.35% | $648K | 3,142 | US |
| 13 | CORCencora, Inc. | Equity | 2.16% | $596K | 1,935 | US |
| 14 | WGSGeneDx Holdings Corp. Class A Common Stock | Equity | 2.12% | $584K | 9,290 | US |
| 15 | MRKMerck & Co., Inc. | Equity | 2.00% | $551K | 5,048 | US |
| 16 | IDXXIdexx Laboratories Inc | Equity | 1.84% | $506K | 903 | US |
| 17 | UNHUNITEDHEALTH GROUP INCORPORATED (Delaware) | Equity | 1.77% | $487K | 1,315 | US |
| 18 | NVONovo-Nordisk A/S | Equity | 1.19% | $328K | 7,766 | DK |
| 19 | VRTXVertex Pharmaceuticals Inc | Equity | 1.16% | $321K | 750 | US |
| 20 | BSXBoston Scientific Corp. | Equity | 1.10% | $303K | 5,252 | US |
| 21 | Newamsterdam Pharma Co NV | Equity | 1.09% | $301K | 10,537 | NL |
| 22 | ALNYAlnylam Pharmaceuticals, Inc. | Equity | 1.08% | $299K | 966 | US |
| 23 | ADPTAdaptive Biotechnologies Corporation Common Stock | Equity | 1.06% | $292K | 20,675 | US |
| 24 | GHGuardant Health, Inc. Common Stock | Equity | 1.02% | $280K | 3,218 | US |
| 25 | MDGLMadrigal Pharmaceuticals, Inc. Common Stock | Equity | 0.90% | $247K | 477 | US |
| 26 | DXCMDexCom, Inc. | Equity | 0.84% | $232K | 3,888 | US |
| 27 | RDNTRadNet, Inc. Common Stock | Equity | 0.77% | $211K | 3,732 | US |
| 28 | IONSIonis Pharmaceuticals, Inc. Common Stock | Equity | 0.58% | $161K | 2,153 | US |
| 29 | NUVLNuvalent, Inc. Class A Common Stock | Equity | 0.58% | $160K | 1,599 | US |
| 30 | SRRKScholar Rock Holding Corporation Common Stock | Equity | 0.57% | $158K | 3,384 | US |
| 31 | PODDInsulet Corporation | Equity | 0.57% | $157K | 913 | US |
| 32 | IMVTImmunovant, Inc. Common Stock | Equity | 0.55% | $152K | 5,589 | US |
| 33 | PRAXPraxis Precision Medicines, Inc. Common Stock | Equity | 0.50% | $138K | 433 | US |
| 34 | AVTXAvalo Therapeutics, Inc. Common Stock | Equity | 0.50% | $137K | 10,218 | US |
| 35 | XENEXenon Pharmaceuticals Inc | Equity | 0.50% | $137K | 2,438 | CA |
| 36 | RLAYRelay Therapeutics, Inc. Common Stock | Equity | 0.48% | $132K | 10,189 | US |
| 37 | TECHBio-Techne Corp. | Equity | 0.48% | $131K | 2,374 | US |
| 38 | ORKAOruka Therapeutics, Inc. Common Stock | Equity | 0.46% | $126K | 1,846 | US |
| 39 | IRTCiRhythm Holdings, Inc. Common Stock | Equity | 0.45% | $123K | 950 | US |
| 40 | Sophia Genetics SA | Equity | 0.33% | $92K | 17,603 | CH |
Find which other funds hold a stock by opening it and choosing "ETFs holding".
Position changes between reports
| Action | Holding | Weight before | Weight after | Shares vs flows | Between reports |
|---|---|---|---|---|---|
| New position | Ascendis Pharma A/S | — | 15.56% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Exit | ASNDAscendis Pharma A/S | 14.45% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | UNHUnitedHealth Group Inc | 4.38% | 1.77% | −74.3% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | ABBVAbbVie Inc | 7.27% | 4.78% | −43.0% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Exit | ADMAADMA Biologics Inc | 2.44% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Exit | GILDGilead Sciences Inc | 2.28% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | INSMInsmed Inc | 2.05% | 3.71% | +71.3% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | ISRGIntuitive Surgical Inc | 2.89% | 4.53% | +41.8% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | RYTMRhythm Pharmaceuticals Inc | 2.47% | 3.79% | +58.6% | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | NVONovo Nordisk A/S | — | 1.19% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | CORCencora Inc | 3.23% | 2.16% | −75.4% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | TECHBio-Techne Corp | 1.48% | 0.48% | −69.4% | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | MDGLMadrigal Pharmaceuticals Inc | — | 0.90% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | BSXBoston Scientific Corp | 1.98% | 1.10% | −25.9% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Exit | HQYHealthEquity Inc | 0.75% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | PODDInsulet Corp | 1.28% | 0.57% | −45.4% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | VRTXVertex Pharmaceuticals Inc | 1.85% | 1.16% | −43.0% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Exit | BIOBio-Rad Laboratories Inc | 0.68% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | NUVLNuvalent Inc | — | 0.58% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | SRRKScholar Rock Holding Corp | — | 0.57% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | ADPTAdaptive Biotechnologies Corp | 0.55% | 1.06% | +109.3% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | PCVXVaxcyte Inc | 4.14% | 4.64% | −13.6% | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | PRAXPraxis Precision Medicines Inc | — | 0.50% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | AVTXAvalo Therapeutics Inc | — | 0.50% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | XENEXenon Pharmaceuticals Inc | — | 0.50% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Exit | ICON PLC | 0.49% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | RLAYRelay Therapeutics Inc | — | 0.48% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | ORKAOruka Therapeutics Inc | — | 0.46% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | GHGuardant Health Inc | 0.58% | 1.02% | +88.2% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | Newamsterdam Pharma Co NV | 0.72% | 1.09% | +35.9% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Exit | BCYCBicycle Therapeutics PLC | 0.36% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | Sophia Genetics SA | — | 0.33% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | IDXXIDEXX Laboratories Inc | 1.51% | 1.84% | +19.3% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | NTRANatera Inc | 2.66% | 2.35% | −18.7% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | ALNYAlnylam Pharmaceuticals Inc | 0.81% | 1.08% | +20.6% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | DXCMDexcom Inc | 0.98% | 0.84% | −13.6% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | RDNTRadNet Inc | 0.90% | 0.77% | −13.6% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | IRTCIRhythm Holdings Inc | 0.51% | 0.45% | −13.5% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | IMVTImmunovant Inc | 0.50% | 0.55% | −13.6% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Decrease | IONSIonis Pharmaceuticals Inc | 0.61% | 0.58% | −13.6% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | WGSGeneDx Holdings Corp | 2.14% | 2.12% | +24.4% | Jan 31, 2026 → Apr 30, 2026 SEC |
Share-count changes are measured after removing what creations and redemptions explain.
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.